Evidence map›Paper›PMID 28910576›Full record

ArticleVirulence2017

Impact of Staphylococcus aureus regulatory mutations that modulate biofilm formation in the USA300 strain LAC on virulence in a murine bacteremia model.

Joseph S Rom, Danielle N Atwood, Karen E Beenken, Daniel G Meeker, Allister J Loughran, Horace J Spencer, Tamara L Lantz, Mark S Smeltzer

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Microorganisms · 2025
    Review
  3. The ability ofInfection and immunity · 2025
    Article
  4. Microorganisms · 2025
    Article
  5. Review
  6. Article
  7. Staphylococcal mastitis in dairy cows.Frontiers in veterinary science · 2024
    Review
  8. Review
  9. The major role ofVirulence · 2023
    Article
  10. A Review of Biofilm Formation ofAntibiotics (Basel, Switzerland) · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Bacterial Quorum Sensing During Infection.Annual review of microbiology · 2020
    Review
  18. Staphylococcal Biofilm Development: Structure, Regulation, and Treatment Strategies.Microbiology and molecular biology reviews : MMBR · 2020
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Joseph S Roma Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Danielle N Atwooda Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Karen E Beenkena Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Daniel G Meekera Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Allister J Loughrana Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Horace J Spencerb Department of Biostatistics , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Tamara L Lantza Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
Mark S Smeltzera Department of Microbiology and Immunology , University of Arkansas for Medical Sciences , Little Rock , AR , USA.
University of Arkansas for Medical Sciences · US

Funding

Arkansas Center for Clinical and Translational ResearchUL1TR000039 · NCATS · UNIV OF ARKANSAS FOR MED SCIS · PI BECK, CORNELIA MARIE, JAMES, LAURA P · 2012 to 2014
$10.0M
Impact of Staphylococcus aureus in osteomyelitis and bone physiologyR01AI119380 · NIAID · UNIV OF ARKANSAS FOR MED SCIS · PI BEENKEN, KAREN E., SMELTZER, MARK S · 2015 to 2025
$4.1M
Center for Protein Structure and FunctionP30GM103450 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI MILLETT, FRANCIS S · 2012 to 2014
$3.2M
NCATS NIH HHS UL1 TR000039NIAID NIH HHS R01 AI119380NIGMS NIH HHS P30 GM103450
6 · The paper itself

Abstract

Staphylococcus aureus causes acute and chronic forms of infection, the latter often associated with formation of a biofilm. It has previously been demonstrated that mutation of atl, codY, rot, sarA, and sigB limits biofilm formation in the USA300 strain LAC while mutation of agr, fur, and mgrA has the opposite effect. Here we used a murine sepsis model to assess the impact of these same loci in acute infection. Mutation of agr, atl, and fur had no impact on virulence, while mutation of mgrA and rot increased virulence. In contrast, mutation of codY, sarA, and sigB significantly attenuated virulence. Mutation of sigB resulted in reduced accumulation of AgrA and SarA, while mutation of sarA resulted in reduced accumulation of AgrA, but this cannot account for the reduced virulence of sarA or sigB mutants because the isogenic agr mutant was not attenuated. Indeed, as assessed by accumulation of alpha toxin and protein A, all of the mutants we examined exhibited unique phenotypes by comparison to an agr mutant and to each other. Attenuation of the sarA, sigB and codY mutants was correlated with increased production of extracellular proteases and global changes in extracellular protein profiles. These results suggest that the inability to repress the production of extracellular proteases plays a key role in attenuating the virulence of S. aureus in acute as well as chronic, biofilm-associated infections, thus opening up the possibility that strategies aimed at the de-repression of protease production could be used to broad therapeutic advantage. They also suggest that the impact of codY, sarA, and sigB on protease production occurs via an agr-independent mechanism.

Indexed as

BiofilmsAnimalsBacteremiaBacterial ProteinsDisease Models, AnimalFemaleGene Expression Regulation, BacterialHumansMiceMutationStaphylococcal InfectionsStaphylococcus aureusVirulenceBacterial ProteinsAgrAalpha toxinbacteremiaprotein Aregulatory mutationsSarAsepsisStaphylococcus aureus

Identifiers

PMID28910576
PMCPMC5810510
OpenAlexW2755460299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.